Pur pose. The ability to establish consistent human tumor xenografts in experim ental animals is a crucial part of preclinical investigations.The goal of this study was to develop a m ethod of establishing a human tumor xenograft in the leg of a nude rat for evaluation of new surgical and molecular methods of treatments of human extremity sarcoma. M ethods and results. Initial attempts to produce sarcoma nodules by subcutaneous injection of a human leiomyosarcoma tumor cell suspension (SKLM S-1) resulted in tumor nodule formation in only four of 10 sites (40% ). The xenograft method was modi® ed to include younger nude rats of a differen t source and substrain (HSD:rnu/rnu, 5± 9 weeks old), treated with 500 cG y whole-body irradiation, and the transplantation of tumor cells or small tumor fragments which had been embedded in M atrigel. These changes improved the tumor take rate per site to 52/52 (100% ). Tumor nodules dem onstrated rapid and progressive growth and histological features consistent with the original human sarcoma. Discussion. Successful human leiomyosarcoma establishment in these nude rats perm its the investigation of sarcoma biology and treatment with surgical procedures for which a mouse model would be inadequate. In this study we identi® ed modi® cations in technique which enhanced the xenografting of a leiomyosarcoma cell line in nude rats; these techniques m ay increase tumor take rates for other tumor types as well.
Introduction
H um an soft tissue sarcom as are a rare grou p of heterogeneous tum ors characterized by aggressive local growth and hem atogenous m etastases, m ost often to the lungs. Surgical resection, with or without radiotherapy, is the cornerstone of the local treatm ent of these sarcomas. Surgical m ethods that allow lim b preservation for patients who would otherwise require am putation have also been developed.
1,2 An exam ple is isolated lim b perfusion (ILP), which is used to deliver high doses of chemotherapeutic agents to an extremity tumor whose vascularity has been temporarily isolated from the rem ainder of the body, thereby preventing patient exposure to system ically toxic drug concentrations. 2 D espite such advances, the overall dism al prognosis for sarcom a patients and the need to im prove current treatm ent options necessitate an active research effor t and reliable preclinical anim al m odels.
3 O rthotopic xenografts of hum an tum ors in nude m ice are an accepted m odel for in vivo biological and preclinical studies; 4 however the sm all size of m ice lim its their usefulness in m any surgical applications. T he investigation of sarcom a tum or biology and surgical techniques, such as ILP, in a larger laborator y anim al therefore requires that a consistently producible hum an tumor xenograft m odel be achievable in such an anim al.
We report here a m ethod of generating hum an sarcom as in the leg or¯ank of the nude rat that results in excellent tum or take rates and consistent, reliable growth patterns. T he principles of xenograft establishm ent described here for sarcom as m ay be useful for research applications involving other types of hum an tumors.
M ethods

Anim als
Fem ale Row ett nu d e rats, 4± 6 weeks old , w ere obtained from the N ational Cancer Institute (Frederick C ancer Research Facility, Frederick, M D ; strain C r:N IH -R N U ) or from H arlan Sprag ue± D aw ley (Indianapolis, IN ; strain HSD :rnu/rnu). T he anim als were housed three per cage in sterilized rat m icroisolator cages (Lab Products, Seafo rd, D E) containing corncob bedding (Bed' o' C ob; N ortheastern Products C o r p., C a spa in , M O ). T he tem p eratu re w as m aintained at 22±2Ê C and hum idity at 50±10% . Anim als were provided a 12-h light± dark cycle and ad libitum autoclaved food (Harlan-Teklad, M adison, W I) and water throughout the study. T he experiments were approved by the Institutional Anim al Care and U se C om m ittee at T he 
Tum ors
The human leiomyosarcom a SKLM S-1 was obtained from the Am erican Type C ulture Collection (Rockville, M D ). SKL M S-1 is a well-characterized hum an sarcoma cell line and contains a known p53 tum or suppressor gene m utation. 
7,8
Radiation N ude rats received a single dose of 500 cG y totalbody irradiation which was adm inistered using a cobalt-60 source (Eldorado-8 teletherapy m achine, A to m ic E n ergy o f C an a d a , L td .) d eliver in g approxim ately 57 cG y/m in. D uring irradiation, awake rats were placed in a m ouse microisolator cage and co ve red w ith a 1 ¤ 4-i n ch so lid L u cite p latfo r m constructed to ® t the inner cage dim ensions and m inimally contact the dorsal surface of the rats. T he rats were used in tum or im plantation experim ents 4 days after irradiation.
Tum or im plantation
Rats were anesthetized using M etophane (M allinckrodt Veterinary, M undelein, IL) in an inhalation anesthetic cham ber. The skin over the im plantation site was wiped clean w ith 70% ethanol. For injection, 200 m l of SKLM S-1 cell suspension containing 10 3
10
6 cells was inoculated into the subcutaneous tissue in the rat¯ank or hind leg using a tuberculin syringe w ith a 2 8-G a n eed le ( B ecto n -D ick in so n ). F o r im plantation, a 5-m m incision was m ade in the skin overlying the¯ank or leg, and a single 3 3 2-m m sliver of tum or tissue was delivered through the incision site using a trocar and deposited 1 cm away in the subcutaneous tissue. T he skin was closed using a single wound clip (Becton-D ickinson).
Results
T he goal of these experim ents was to establish a m ethod of tum or im plantation that would lead to consistent and reliable hum an sarcom a xenografts in the rat¯ank and leg. The results of the experim ents are sum m arized in Table 1 . T he initial experim ents were conducted using eight N C I nude rats which were either 9 weeks old (n=5) or 12 weeks old (n=3). All rats were subcutaneously inoculated at each injection site w ith a 200-m l su spen sion o f 10 3 10 6 PI, post-implantation.
SKLM S-1 sarcom a cells in PBS. T here were two injection sites per rat, the¯ank and hind lim b, and these were inspected daily by visual exam ination and palp ation for evidence of tum or grow th. In the group of rats inoculated at 9 weeks of age, one rat developed a sm all tum or nodule (5 m m ) in the leg 2 weeks post-injection; no rat had evidence of tum or growth in the¯ank. At 3 weeks post-injection, two rats had tum or nodules in the leg and another two in thē ank. At both 4 and 12 weeks post-injection, only one rat retained a growing tumor nodule in the leg; the n o d u le in th e oth er rat h ad spo n tan eo u sly regressed. Three rats had tumor nodules in the¯ank. M axim um tum or nodule diam eter at 12 weeks was 1.5 cm. At no time did any of the three rats inoculated at 12 weeks of age exhibit tum or growth at any site. For the younger rats, therefore, the overall tum or take rate for all sites by 12 weeks was four of 10 (40%) and respective values for the leg and¯ank speci® cally were one of ® ve (20% ) and three of ® ve (60%).
T he tum or take rates o bser ve d w ith inje ction of SK L M S-1 cells in PBS were un suitable for stud ies that requ ire m any rats an d tim ely d evelopm en t of tu m o r n o d u l es. To o p tim iz e t h e s u c c es s o f xenog raftin g these sarcom a cells, we m od i® ed the above im plan tation proced ure by using you nger rats (5± 7 weeks old) from a differen t supplier (H arlan Sprague± D awley), treating them w ith 500 cG y totalbody irradiation to achieve fur ther im m un osu ppress io n , a d d i n g M atr ig e l to th e tu m o r, a n d tran splan ting tum or fra gm en ts har vested fro m a do nor rat. Although each of these changes in dividually elicited som e im provem ent (data n ot show n), the best resu lts were achieved w hen all m od i® cation s were applied .
Four days after irradiating a group of 10 7-week-old rats, SKLM S-1 tum or in 3 3 2-m m slivers coated with M atrigel was im planted subcutaneously in either three sites or four sites per rat to yield 36 total inoculation sites. Six rats were inoculated in both¯anks and both legs; four rats were inoculated in one¯ank and both legs. N o radiation-related adverse effects, such as skin changes or lethargy, were noted. Eight days after im plantation, tumor nodules were easily palpable at all sites, and all grew to a diameter of 1 cm by 2 weeks post-im plantation (Fig. 1) . T he tum or take rate per site w ith this m ethod was 36/36 (100% ). A sim ilar time course of tum or grow th and the sam e xenotransplantation rate was achieved in slightly older rats who were also irradiated at 12 weeks of age. In this group of rats, tum or nodule form ation occurred at 12/12 sites (100% ). Fu rtherm ore, two H arlan Sprague± D awley rats were irradiated at 7± 9 weeks of age and injected subcutaneously in both¯anks w ith 
Discussion
The use of hum an xenografts in laboratory anim als is an essential com ponent of preclinical cancer therapy investigations. Xenografts of hum an tumors are m ost com m only m odeled in nude m ice, 4 w hose sm all size is convenient for m ost experim ental app lications but lim its the investigation of m ore com plex surgical procedures. For these kinds of studies, the nude rat is m ore approp riate. T he nude rat has an autosom al recessive m utation w hich results in the lack of a functional thym us. 9 T lym phocytes and cell-m ediated im m unity are m arkedly reduced, and xenograft rejection is dim inished or delayed. 9 Because of their larger size, nude rats perm it easier perform ance of surgical m anipulations, especially on sm all structures such as blood vessels. T he prim ary disadvantage of the nude rats is their relative im m une com petence com pared to athym ic nude m ice. M any human tumor xenografts in nude rats show either greatly dim inished tum or take rates co m p ared to th ose in n u d e m ice o r spontaneous regression of the tum ors. 10± 16 Selected interventions, such as w hole-body irradiation, have been reported to im prove tum or take rates for hum an lung cancer m odels in nude rats. 17, 18 T he purpose of these experim ents was to identify com ponents of tumor im plantation technique that would lead to consistent and reliable hum an sarcom a xenografts in the rat¯ank and leg, sites im portant for sarcom a research app lications. Par ticularly necessar y was the establishm ent of similarly sized tumor nodules growing at a predictable rate in rat lim bs intended to undergo ILP w ith biochem otherapeutic agents. In the pro cess of tr yin g to establish this xeno graft m ethod, we observed highly variable tumor take rates and tum or growth properties. Such variability does not seem to affe ct syngeneic rat sarcom a transplants, which lead to tum or establishm ent within about 1 week. 19, 20 A m ethod of direct tum or im plantation used with a syngeneic rat ® brosarcom a for successfu l ILP studies w ith genetic therapy 21 did not result in con sisten t tum or take rates w hen applied to the hu m an S K L M S -1 leio m yo sarco m a tu m o r. T h is circum stance allowed us to identify several factors that app ear to be im portant in determ ining xenograft tum or take rates. These include the vendor source, strain and age of rat, presence or absence of wholebody irradiation, form of transplanted tum or cells (solid fragm ent of tum or tissue versus cell suspension), and presence or absence of a xenograft environm ent enriched with grow th factors. T he need for these m odifcations re¯ects varying degrees of im m une com petency of nude rats, the m alignant phenotype of the particular tum or, and the im portance of local tum or grow th factors in esta b lish in g xen o g r afts. T h e im m u n o lo g ic al characteristics of nude rats m ay vary depending on the rats' source and strain. 9 M axim um im m unosuppression m ay require changing rat strains or vendor sources, using younger rats (£ 11 weeks old), and further lym phocyte depletion of the selected rats through whole-body irradiation. T he inherent aggressiveness of a hum an tum or m ay dictate how m any of these m odi® cations are needed to ensure xenograft estab lish m en t. Tota l-b o d y ir rad iation a lo n e w as su ffi cie n t in so m e lu n g ca n cer m o d els. 17, 18, 20 Manipulation of the xenograft environm ent m ay also im p rove tu m o r ta ke rates. Im p lan tatio n o f a n established tumor fragm ent harvested from a donor rat m ay enhance intercellular interactions in a new host, com pared to inoculation of a loose suspension of cultured tum or cells. 22, 23 The cellular environment m ay be further enhanced by exogenous grow th factors. M atrigel is a solubilized basem ent m embrane preparation. We found that the adm inistration of the tum or fragm ents in conjunction w ith M atrigel, which contains extracellular m atrix proteins and grow th factors, 7,8 resulted in optimum tum or take rates and grow th pattern consistency in our sarcom a m odel. In su m m ar y, w e have repo r ted a m eth o d o f producing hum an sarcom a xenografts in the leg of the nude rat, using a hum an leiomyosarcom a cell line, which yield s excellent tum or take rates and consistent, reliable growth patterns. T he use of young n ud e rats of a select strain, com bin ed w ith the adm inistration of 500 cGy whole-body irradiation and the use of Matrigel-soaked tumor implants, resulted in high tumor take rates with no tumor nodule regression over time. T his m akes it possible to continue the investigation o f such therap eu tic agents as chemotherapy drugs or gene therapy constructs, and also brin gs to atten tion aspects of xen og raftin g technique that may be m odi® ed to im prove tumor take rates of other human tumor xenografts in nude rats.
